615
Views
4
CrossRef citations to date
0
Altmetric
Review

Pharmacotherapy for trichotillomania in adults

&
Pages 1455-1466 | Received 02 Mar 2020, Accepted 23 Apr 2020, Published online: 07 Jul 2020

References

  • Woods DW , Flessner CA , Franklin ME , et al. The trichotillomania impact project (TIP): exploring phenomenology, functional impairment, and treatment utilization. J Clin Psychiatry. 2006;67:1877–1888.
  • Christenson GA , Mackenzie TB , Mitchell JE. Characteristics of 60 adult chronic hair pullers. Am J Psychiatry. 1991;148:365–370.
  • Odlaug BL , Kim SW , Grant JE. Quality of life and clinical severity in pathological skin picking and trichotillomania. J Anxiety Disord. 2010;24:823–829.
  • American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4th ed. Washington: American Psychiatric Association; 1994.
  • American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.
  • Substance Abuse and Mental Health Services Administration . Impact of the DSM-IV to DSM-5 changes on the national survey on drug use and health. Rockville, Md: Substance Abuse and Mental Health Services Administration (US); 2016 Jun. CBHSQ Methodology Report..
  • Grant JE , Chamberlain SR . Trichotillomania. Am J Psychiatry. 2016;173:868–874.
  • Lamothe H , Baleyte J-M , Mallet L , et al. Trichotillomania is more related to tourette disorder than to obsessive-compulsive disorder. Brazilian J. Psychiatry.. 2020;42(1):87–104.
  • Van Ameringen M , Mancini C , Oakman JM , et al. The potential role of haloperidol in the treatment of trichotillomania. J Affect Disord. 1999;56:219–226.
  • Diefenbach GJ , Tolin DF , Hannan S , et al. Trichotillomania: impact on psychosocial functioning and quality of life. Behav Res Ther. 2005;43:869–884.
  • Christenson G . Trichotillomania: from prevalence to comorbidity. Psychiatr. Times.. 1995; 521–527.
  • Cohen LJ , Stein DJ , Simeon D , et al. Clinical profile, comorbidity, and treatment history in 123 hair pullers: A survey study. J Clin Psychiatry. 1995;56:319–326.
  • Gupta MA , Gupta AK , Knapp K . Trichotillomania:Demographic and Clinical Features From a Nationally Representative US Sample. Skinmed. 2015;13:455–460.
  • Lochner C , Grant JE , Odlaug BL , et al. DSM-5 field survey: hair-pulling disorder (trichotillomania). Depress Anxiety. 2012;29:1025–1031.
  • Woods DW , Houghton DC . Diagnosis, evaluation, and management of trichotillomania. Psychiatr Clin North Am. 2014;37:301–317.
  • Christenson GA , MacKenzie TB , Mitchell JE . Adult men and women with trichotillomania. A comparison of male and female characteristics. Psychosomatics. 1994;35:142–149.
  • Koran LM , Ringold A , Hewlett W . Fluoxetine for trichotillomania: an open clinical trial. Psychopharmacol. Bull. 1992;28:145–149.
  • Stein DJ , Bouwer C , Maud CM . Use of the selective serotonin reuptake inhibitor citalopram in treatment of trichotillomania. Eur Arch Psychiatry Clin Neurosci. 1997;247:234–236.
  • Gadde KM , Ryan Wagner H , Connor KM , et al. Escitalopram treatment of trichotillomania. Int Clin Psychopharmacol. 2007;22:39–42.
  • Grant JE , Odlaug BL , Chamberlain SR , et al. Dronabinol, a cannabinoid agonist, reduces hair pulling in trichotillomania: A pilot study. Psychopharmacology (Berl). 2011;218(3):493–502.
  • Van Ameringen M , Mancini C , Patterson B , et al. A randomized, double-blind, placebo-controlled trial of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2010;71:1336–1343.
  • Christenson GA , Mackenzie TB , Mitchell JE , et al. A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. Am J Psychiatry. 1991;148:1566–1571.
  • Swedo SE , Leonard HL , Rapoport JL , et al. A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). N Engl J Med. 1989;321:497–501.
  • Grant JE , Odlaug BL , Suck WK . N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66:756–763.
  • Grant J . Trichotillomania (hair pulling disorder). Indian J Psychiatry. 2019;61:S136–S139.
  • Keuthen NJ , Curley EE , Scharf JM , et al. Predictors of comorbid obsessive-compulsive disorder and skin-picking disorder in trichotillomania. Ann. Clinical Psychiatry. 2016;28:280–288.
  • Grant JE , Redden SA , Medeiros GC , et al. Trichotillomania and its clinical relationship to depression and anxiety. Int J Psychiatry Clin Pract. 2017;21:302–306.
  • Swedo SE , Leonard HL . Trichotillomania. An obsessive compulsive spectrum disorder? Psychiatr. Clin. North Am. 1992;15: 777–790.
  • Schlosser S , Black DW , Blum N , et al. The demography, phenomenology, and family history of 22 persons with compulsive hair pulling. Ann. Clin. Psychiatry. 1994;6:147–152.
  • Christenson G , Mansueto C . Trichotillomania: descriptive characteristics and phenomenology. Trichotillomania. Washington, DC: American Psychiatric Press; 1999. p. 1–41.
  • Winchel RM , Jones JS , Stanley B , et al. Clinical characteristics of trichotillomania and its response to fluoxetine. J Clin Psychiatry. 1992;53:304–308.
  • Sharma V , Corpse C . Lithium treatment of trichotillomania with comorbid bipolar II disorder. Arch Womens Ment Health. 2008;11:305–306.
  • Sharma V . Treatment of trichotillomania and subthreshold bipolar disorder with lithium. Bipolar Disord. 2019;21:803–805.
  • White MP , Koran LM . Open-label trial of aripiprazole in the treatment of trichotillomania. J Clin Psychopharmacol. 2011;31:503–506.
  • Stemberger RM , Thomas AM , Mansueto CS , et al. Personal toll of trichotillomania: behavioral and interpersonal sequelae. J Anxiety Disord. 2000;14:97–104.
  • Grant JE , Odlaug BL . Clinical characteristics of trichotillomania with trichophagia. Compr Psychiatry. 2008;49:579–584.
  • Christenson GA , Pyle RL , Mitchell JE . Estimated lifetime prevalence of trichotillomania in college students. J Clin Psychiatry. 1991;52:415–417.
  • Grant JE , Chamberlain SR , Redden SA , et al. Placebo response in trichotillomania. Int Clin Psychopharmacol. 2017;32:350–355.
  • Stanley MA , Breckenridge JK , Swann AC , et al. Fluvoxamine treatment of trichotillomania. J Clin Psychopharmacol. 1997;17:278–283.
  • Ninan PT , Knight B , Kirk L , et al. A controlled trial of venlafaxine in trichotillomania: interim phase i results. Psychopharmacol. Bull. 1998;34:221–224.
  • Stewart RS , Nejtek VA . An open-label, flexible-dose study of olanzapine in the treatment of trichotillomania. J Clin Psychiatry. 2003;64:49–52.
  • Lochner C , Seedat S , Niehaus DJH , et al. Topiramate in the treatment of trichotillomania: an open-label pilot study. Int Clin Psychopharmacol. 2006;21:255–259.
  • Streichenwein SM , Thornby JI . A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. Am J Psychiatry. 1995;152:1192–1196.
  • Grant JE , Odlaug BL , Schreiber LRN , et al. The opiate antagonist, naltrexone, in the treatment of trichotillomania: results of a double-blind, placebo-controlled study. J Clin Psychopharmacol. 2014;34:134–138.
  • O’Sullivan R , Christenson G , Stein D . Pharmacotherapy of trichotillomania. In: Stein D , Christenson GA , Hollander E , editors. Trichotillomania. Washington, DC: American Psychiatric Press; 1999. p. 93–123.
  • Dougherty DD , Loh R , Jenike MA , et al. Single modality versus dual modality treatment for trichotillomania: sertraline, behavioral therapy, or both? J. Clin Psychiatry. 2006;67:1086–1092.
  • Ninan PT , Rothbaum BO , Marsteller FA , et al. A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. J Clin Psychiatry. 2000;61:47–50.
  • van Minnen A , Hoogduin KAL , Keijsers GPJ , et al. Treatment of trichotillomania with behavioral therapy or fluoxetine: A randomized, waiting-list controlled study. Arch Gen Psychiatry. 2003;60:517–522.
  • Hamilton M . A rating scale for depression. Journal of Neurology, Neurosurgery & Psychiatry. 1960;23(1):56–62.
  • Hamilton M . The assessment of anxiety states by rating. Br. J. Med. Psychol. 1959;32: 50–55.
  • Beck AT , Ward CH , Mendelson M , et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571.
  • Cooper J . The leyton obsessional inventory. Psychol Med. 1970;1:48–64.
  • Goodman WK , Price LH , Rasmussen SA , et al. The yale-brown obsessive compulsive scale: i. development, use, and reliability. Arch Gen Psychiatry. 1989;46:1006–1011.
  • Insel TR , Murphy DL , Cohen RM , et al. Obsessive-Compulsive Disorder: A Double-blind Trial of Clomipramine and Clorgyline. Arch Gen Psychiatry. 1983;40:605–612.
  • Guy W . ECDEU assessment manual for psychopharmacology. Rockville, Md: U.S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs; 1976.
  • Stanley MA , Prather RC , Wagner AL , et al. Can the yale-brown obsessive compulsive scale be used to assess trichotillomania? A preliminary report. Behav Res Ther. 1993;31:171–177.
  • Keuthen NJ , O Sullivan RL , Ricciardi JN , et al. The Massachusetts general hospital (MGH) hairpulling scale: 1. development and factor analyses. Psychother Psychosom. 1995;64:141–145.
  • Swedo SE , Lenane MC , Leonard HL . Long-term treatment of trichotillomania (hair pulling). N Engl J Med. 1993;329:141–142.
  • Christenson GA , Popkin MK , Mackenzie TB , et al. Lithium treatment of chronic hair pulling. J Clin Psychiatry. 1991;52:116–120.
  • Berk M , Mckenzie H , Dodd S . Trichotillomania: Response to lithium in a person with comorbid bipolar disorder [3]. Hum Psychopharmacol. 2003;18:576–577.
  • Sharma V . Pharmacotherapy of trichotillomania. J Psychiatry Neurosci. 2017;42:E5–E6.
  • Reid TL . Treatment of generalized anxiety disorder and trichotillomania with buspirone. Am J Psychiatry. 1992;149:573–574.
  • Gabriel A . A case of resistant trichotillomania treated with risperidone-augmented fluvoxamine. Can J Psychiatry. 2001;46:285–286.
  • Ravindran AV , Lapierre YD , Anisman H Obsessive-compulsive spectrum disorders: effective treatment with paroxetine.
  • O’Sullivan RL , Keuthen NJ , Rodriguez D , et al. Venlafaxine treatment of trichotillomania: an open series of ten cases. CNS Spectr. 1998;3:56–63.
  • Khouzam HR , Battista MA , Byers PE . An overview of trichotillomania and its response to treatment with quetiapine. Psychiatry. 2002;65:261–270.
  • Crescente JAB , Guzman CS , Tavares H . Quetiapine for the treatment of trichotillomania. Brazilian J. Psychiatry. 2008;30: 402.
  • Stein DJ , Hollander E . Low-dose pimozide augmentation of serotonin reuptake blockers in the treatment of trichotillomania. J Clin Psychiatry. 1992;53:123–126.
  • Sharma V . Loss of response to antidepressants and subsequent refractoriness: diagnostic issues in a retrospective case series. J Affect Disord. 2001;64:99–106.
  • Fornaro M , Anastasia A , Novello S , et al. The emergence of loss of efficacy during antidepressant drug treatment for major depressive disorder: an integrative review of evidence, mechanisms, and clinical implications. Pharmacol Res. 2019;139:494–502.
  • Gitlin M . Lithium side effects and toxicity: prevalence and management strategies. Int J Bipolar Disord. 2016;4:27.
  • Aydin EP , Kenar JG , Tutan A , et al. Repetitive transcranial magnetic stimulation for treatment of trichotillomania: case series. Clin. Psychopharmacol. Neurosci. 2019.
  • Beck AT , Epstein N , Brown G , et al. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897.
  • Flessner CA , Penzel F , Keuthen NJ . Current treatment practices for children and adults with trichotillomania: consensus among experts. Cogn. Behav. Pract. 2010;17: 290–300.
  • Rothbart R , Amos T , Siegfried N , et al. Pharmacotherapy for trichotillomania. In: Cochrane database syst. rev. John Wiley & Sons; 2013. p. 1–35.
  • McGuire JF , Ung D , Selles RR , et al. Treating trichotillomania: A meta-analysis of treatment effects and moderators for behavior therapy and serotonin reuptake inhibitors. J Psychiatr Res. 2014;58:76–83.
  • Morris SH , Zickgraf HF , Dingfelder HE , et al. Habit reversal training in trichotillomania: guide for the clinician. Expert Rev Neurother. 2013;13:1069–1077.
  • Rehm I , Moulding R , Nedeljkovic M . Psychological treatments for trichotillomania: update and future directions. Australas Psychiatry. 2015;23:365–368.
  • Azrin NH , Nunn RG , Frantz SE . Treatment of hairpulling (Trichotillomania): A comparative study of habit reversal and negative practice training. J Behav Ther Exp Psychiatry. 1980;11:13–20.
  • Franklin ME , Zagrabbe K , Benavides KL . Trichotillomania and its treatment: A review and recommendations. Expert rev. neurother. 2011;11:1165–1174. 
  • Mansueto CS , Goldfinger Golomb R , McCombs Thomas A , et al. A Comprehensive Model for Behavioral Treatment of Trichotillomania. Cogn. Behav. Pract. 1999;6:23–43.
  • First M, Williams J, Karg R, et al . Structured Clinical Interview for DSM-5 Disorders: clinician Version (SCID-5-CV). Arlington, VA: American Psychiatric Association; 2015.
  • Keuthen NJ , O’Sullivan RL , Hayday CF , et al. The relationship of menstrual cycle and pregnancy to compulsive hairpulling. Psychother Psychosom. 1997;66:33–37.
  • Hirschfeld RMA . The mood disorder questionnaire: a simple, patient-rated screening instrument for bipolar disorder. Prim. Care Companion J. Clin. Psychiatry. 2002;4: 9–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.